IP Verse

Ceva Sante Animale competitive analysis

Latest publications and patents of Ceva Sante Animale New

Explore the latest publications and patents granted to Ceva Sante Animale, showcasing their recent innovations and technological advancements.

Last updated on: Oct 1, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Ceva Sante Animale
EP2831246	Nov 6, 2024	Multivalent Recombinant Avian Herpes Viruses And Vaccines For Immunizing Avian Species	Patent Maintained As Amended
EP3041939	Mar 27, 2019	Recombinant Marek'S Disease Viruses And Uses Thereof	Opposition Rejected
EP2750704	Oct 4, 2017	Synthetic Capsid Proteins And Uses Thereof	Revoked

Latest oppositions filed by Ceva Sante Animale

Explore patent oppositions filed by Ceva Sante Animale against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3485890	Treatment Of Metabolic Disorders In Canine Animals	BOEHRINGER INGELHEIM VETMEDICA	Feb 9, 2024
EP3883603	A Vaccine For Protection Against Streptococcus Suis	INTERVET	Sep 19, 2023
EP3035958	Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Jul 26, 2023
EP3473101	Isoxazoline Compositions And Their Use As Antiparasitics For Felines	INTERVET	Feb 11, 2022
EP2275132	Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Dec 2, 2021
EP3351267	Vaccine For Protection Against Lawsonia Intracellularis	INTERVET	May 4, 2021
EP3127551	Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Apr 27, 2021
EP3253409	A Vaccine For Use Against Subclinical Lawsonia Infection In A Pig	INTERVET	Feb 5, 2021
EP3253410	A Vaccine For Use Against Subclinical Lawsonia Infection In A Pig	INTERVET	Feb 5, 2021
EP2545777	Isoxazoline Compositions And Their Use As Antiparasitics	INTERVET	Dec 11, 2020

Latest patents of Ceva Sante Animale opposed by its competitors

Explore Ceva Sante Animale's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP2831246	Nov 6, 2024	Multivalent Recombinant Avian Herpes Viruses And Vaccines For Immunizing Avian Species	1
EP3041939	Mar 27, 2019	Recombinant Marek'S Disease Viruses And Uses Thereof	1
EP2750704	Oct 4, 2017	Synthetic Capsid Proteins And Uses Thereof	1

Latest PTAB cases involving Ceva Sante Animale

Discover the latest PTAB cases involving Ceva Sante Animale, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ceva Sante Animale with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
CEVA SANTE ANIMALE	21	3	-	-	Highly Aggressive
BOEHRINGER INGELHEIM ANIMAL HEALTH USA	16	30	2	-	Balanced
BOEHRINGER INGELHEIM VETMEDICA	18	29	-	4	Balanced
INTERVET	11	34	4	1	Balanced